Aarey Drugs & Pharmaceuticals Ltd will announce their Q4 and FY2026 audited financial results at a board meeting on May 29, 2026. A trading restriction for designated individuals has been implemented, lasting 48 hours following the results announcement.

Aarey Drugs shares dropped by 5%, reaching Rs 81.1 due to excessive sell orders, causing an unfulfilled demand and a freeze in the price.

Aarey Drugs & Pharmaceuticals experienced a notable surge today, reaching an upper circuit of 5%. The stock price peaked at Rs 75.03, indicating strong buying interest with no visible selling activity.

Based on current analysis, Aarey Drugs & Pharmaceuticals Ltd receives a 'Strong Sell' recommendation as of November 28, 2025. This evaluation considers the company's overall health and recent trends as of April 6, 2026. Investors may want to reconsider their holdings in this stock.

Aarey Drugs shares reached a high of 4.45% upper circuit on April 6, 2026, closing at Rs 56.39. This surge in price indicates strong buyer interest with no sellers participating in the market.